DE60117555D1 - Bewertungssystem für die vorhersage von krebsrezidiven - Google Patents

Bewertungssystem für die vorhersage von krebsrezidiven

Info

Publication number
DE60117555D1
DE60117555D1 DE60117555T DE60117555T DE60117555D1 DE 60117555 D1 DE60117555 D1 DE 60117555D1 DE 60117555 T DE60117555 T DE 60117555T DE 60117555 T DE60117555 T DE 60117555T DE 60117555 D1 DE60117555 D1 DE 60117555D1
Authority
DE
Germany
Prior art keywords
cancer
recurrence
prediction
proteins
chip
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60117555T
Other languages
English (en)
Other versions
DE60117555T2 (de
Inventor
Masaaki Oka
Yoshiko Hamamoto
Hisafumi Okabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE60117555D1 publication Critical patent/DE60117555D1/de
Publication of DE60117555T2 publication Critical patent/DE60117555T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hematology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DE60117555T 2001-07-23 2001-07-23 Bewertungssystem für die vorhersage von krebsrezidiven Expired - Lifetime DE60117555T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2001/006330 WO2003010337A1 (en) 2001-07-23 2001-07-23 Scoring system for the prediction of cancer recurrence

Publications (2)

Publication Number Publication Date
DE60117555D1 true DE60117555D1 (de) 2006-04-27
DE60117555T2 DE60117555T2 (de) 2007-01-11

Family

ID=11737575

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60117555T Expired - Lifetime DE60117555T2 (de) 2001-07-23 2001-07-23 Bewertungssystem für die vorhersage von krebsrezidiven

Country Status (9)

Country Link
US (2) US7747389B2 (de)
EP (1) EP1409716B1 (de)
JP (1) JP4353796B2 (de)
CN (1) CN100398663C (de)
AT (1) ATE318935T1 (de)
CA (1) CA2455649C (de)
DE (1) DE60117555T2 (de)
ES (1) ES2254450T3 (de)
WO (1) WO2003010337A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7747389B2 (en) 2001-07-23 2010-06-29 F. Hoffmann-La Roche Ag Scoring system for the prediction of cancer recurrence
GB2398379A (en) * 2003-02-11 2004-08-18 Qinetiq Ltd Automated digital image analysis
US20070292423A1 (en) 2003-04-08 2007-12-20 Masaaki Oka Method of Defining the Differentiation Grade of Tumor
WO2004092365A1 (ja) * 2003-04-13 2004-10-28 Kyushu Tlo Company Limited 肝障害関連遺伝子群の抽出選択法およびそれを用いた肝障害もしくは肝機能評価・診断方法
US20050112622A1 (en) * 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
EP1661991A4 (de) * 2003-08-24 2007-10-10 Univ Nihon Mit hepatozellulärem karzinom assoziiertes gen
FR2861744A1 (fr) * 2003-11-05 2005-05-06 Biomerieux Sa Procede pour le pronostic du cancer du sein
US8135595B2 (en) 2004-05-14 2012-03-13 H. Lee Moffitt Cancer Center And Research Institute, Inc. Computer systems and methods for providing health care
FR2881143B1 (fr) * 2005-01-27 2010-12-17 Librophyt Systeme de production de terpenoides dans les plantes
US20070072175A1 (en) * 2005-05-13 2007-03-29 Biogen Idec Ma Inc. Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
KR101133243B1 (ko) * 2009-10-29 2012-04-06 국립암센터 암의 진단 및 치료를 위한 ｅＩＦ３ｍ의 용도
CN104200060A (zh) * 2014-07-30 2014-12-10 福建医科大学附属第一医院 预测巨大肝癌患者术后近期复发转移概率的模型及方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5862304A (en) * 1990-05-21 1999-01-19 Board Of Regents, The University Of Texas System Method for predicting the future occurrence of clinically occult or non-existent medical conditions
US6025128A (en) * 1994-09-29 2000-02-15 The University Of Tulsa Prediction of prostate cancer progression by analysis of selected predictive parameters
CA2229427A1 (en) 1995-09-12 1997-03-20 The General Hospital Corporation Method for early detection of ovarian cancer
US5800347A (en) 1995-11-03 1998-09-01 The General Hospital Corporation ROC method for early detection of disease
WO1998056953A1 (en) * 1997-06-10 1998-12-17 Johns Hopkins University School Of Medicine Methods for thyroid cell detection
US6128608A (en) * 1998-05-01 2000-10-03 Barnhill Technologies, Llc Enhancing knowledge discovery using multiple support vector machines
DE19840671A1 (de) * 1998-08-26 2000-03-02 Stiftung Tumorbank Basel Verfahren zur Diagnose von Rezidiven bei nodal-negativem Brustkrebs
US6647341B1 (en) * 1999-04-09 2003-11-11 Whitehead Institute For Biomedical Research Methods for classifying samples and ascertaining previously unknown classes
CA2376831A1 (en) 1999-06-29 2001-01-04 Intercet, Ltd. Human cancer virtual simulation system
WO2001018542A2 (en) 1999-09-03 2001-03-15 Millennium Pharmaceuticals, Inc. Identification, assessment, prevention, and therapy of ovarian cancer
CA2390305A1 (en) 1999-11-03 2001-05-10 Oncotech, Inc. Methods for cancer prognosis and diagnosis
CN1433481A (zh) 1999-11-30 2003-07-30 奥克索化学有限公司 通过基因表达分析评价和预测临术预后
EP1410304A2 (de) * 2001-03-26 2004-04-21 Epigenomics AG Verfahren zur epigenetischen merkmalauswahl
US6728642B2 (en) 2001-03-29 2004-04-27 E. I. Du Pont De Nemours And Company Method of non-linear analysis of biological sequence data
US7243112B2 (en) * 2001-06-14 2007-07-10 Rigel Pharmaceuticals, Inc. Multidimensional biodata integration and relationship inference
US7747389B2 (en) 2001-07-23 2010-06-29 F. Hoffmann-La Roche Ag Scoring system for the prediction of cancer recurrence
US20070292423A1 (en) 2003-04-08 2007-12-20 Masaaki Oka Method of Defining the Differentiation Grade of Tumor

Also Published As

Publication number Publication date
EP1409716B1 (de) 2006-03-01
EP1409716A1 (de) 2004-04-21
CA2455649C (en) 2009-11-10
JP2004536610A (ja) 2004-12-09
US20120065892A1 (en) 2012-03-15
JP4353796B2 (ja) 2009-10-28
ATE318935T1 (de) 2006-03-15
US8655597B2 (en) 2014-02-18
WO2003010337A1 (en) 2003-02-06
US7747389B2 (en) 2010-06-29
DE60117555T2 (de) 2007-01-11
CA2455649A1 (en) 2003-02-06
CN100398663C (zh) 2008-07-02
US20040234988A1 (en) 2004-11-25
CN1549864A (zh) 2004-11-24
ES2254450T3 (es) 2006-06-16

Similar Documents

Publication Publication Date Title
DE60117555D1 (de) Bewertungssystem für die vorhersage von krebsrezidiven
BR0212211A (pt) Diagnóstico de carcinomas
Tu et al. Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues
Li et al. Distinct mechanisms of transcriptional pausing orchestrated by GAGA factor and M1BP, a novel transcription factor
Mansson et al. Pearson Correlation Analysis of Microarray Data Allows for the Identification of Genetic Targets for Early B-cell Factor*[boxs]
ATE373239T1 (de) Serum macrophage migration inhibitory factor (mif) als marker für prostata krebs
EP2404998A3 (de) Zusammensetzung und Verfahren zur Diagnose von Nierenkrebs und zur Vorhersage einer Prognose für einen Nierenkrebspatienten
WO2006036788A3 (en) Methods and compositions for evaluating breast cancer prognosis
WO2007041342A3 (en) Labeled nucleotide analogs and uses therefor
WO2003052099A3 (en) Methods of parallel gene cloning and analysis
Nishiu et al. Microarray analysis of gene‐expression profiles in diffuse large B‐cell lymphoma: identification of genes related to disease progression
WO1995034650A3 (en) Mn gene and protein
Cordon-Obras et al. Identification of sequence-specific promoters driving polycistronic transcription initiation by RNA polymerase II in trypanosomes
Higuchi et al. Differentially expressed genes associated with cis‐diamminedichloroplatinum (II) resistance in head and neck cancer using differential display and cDNA microarray
WO2002014550A3 (en) Transcription factor target gene discovery
KR100901128B1 (ko) 탈리도마이드 처리에 따른, 최기형성 유발 약물 검색용마커유전자 및 이를 이용한 검색 방법
CA2521876A1 (en) Method of defining the differentiation grade of tumor
Wang Finding primary targets of transcriptional regulators
Nakanishi et al. Recent advances in DNA microarrays
EP3714070A1 (de) Neuartige cip2a-variante und verwendung davon
RU2005128277A (ru) Антитело против опухолеспецифичных антигенов в качестве мишени
TW200712493A (en) Tumor marker for ovarian cancer diagnosis
SE9900615L (sv) Metod och kit för tidig förutsägelse av cancer
ATE304549T1 (de) Menschliches netrin-1
TR200003695T2 (tr) Anjiyostatin bağlayıcı protein.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition